Report an error

Spotted something inaccurate in “Potent P2Y12 Plus DOAC Raises Bleeding Risk Without Ischemic Benefit in AF-ACS”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.